Joseph M. Feczko

Joseph M. Feczko is a declared insider at 3 companies (board member); the most frequent names are Pfizer Inc, ChemoCentryx, Inc. and Keryx Biopharmaceuticals Inc. In total, 48 filings cover trades dated from 15 February 2006 to 20 October 2022.

Both buying and selling appear: 4 purchases worth €153k, against 6 sales worth €2.6M. Sales outweigh purchases by €2.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 25 share grants and 9 option exercises.

The median purchase comes to €35k.

The newest entry dates from 24 October 2022: a transaction, in ChemoCentryx, Inc. The clock since the last published purchase (16 September 2013) now reads 4,801 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.